. Merchandise and services exports were expected to exhibit slower growth than the previous assessment. Tourism sector was also expected to expand slower. Private consumption was expected to be weighed down due
contraction primarily due to burnt products sales volumes down by 17%. On the upside, revenue and EBITDA realized per ton of burnt product sold were up 14% and 1%, as more value addition through higher quality
of 0.16 million baht from the adjustment of cost over the fair value of biological assets. 5. The financial cost 1.67 million baht ,down from the same period a year before, the 1.82 million baht or
postponed plan and slow down investment, From such situations effected Company performance for quarterly2 2017 as follow; - Decreased on sales from Baht 226.04M in Q2’2016 to Baht 172.88M in Q2’2017 at 23.52
subsidiaries have the revenues from medical treatment of 796.27 million baht, which is a 0.15 % increase from the previous year. The revenues can from the two hospitals are broken down as follows
revenues from medical treatment of 3,621.15 million baht, which is a 6.42 % increase from the previous year. The revenues can from the three hospitals are broken down as follows : - Ramkhamhaeng Hospital
total revenue at 180.99 million Baht, down 111.95 million Baht, or a decrease of 38.22%, compared with the same period of previous year. The Company had a net profit of 1.96 million Baht, an increase of
majority of customers have slow down of investment. Gross Profit The Group's gross profit margin was 151 million baht in the first quarter of 2019, decrease of 97 million baht or 40% from the same period of